O. Bowersox

Immunomodulatory properties of recombinant murine and human tumor necrosis factor.

J. Talmadge, H. Phillips, M. Schneider, 1988, Cancer research.

Therapeutic and toxic activity of tumor necrosis factor is synergistic with gamma interferon.

D. Liggitt, J. Talmadge, O. Bowersox, 1989, Pathology and immunopathology research.

Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.

D. Liggitt, J. Talmadge, H. Shepard, 1987, The American journal of pathology.

Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor.

D. Longo, L. Kwak, O. Bowersox, 1995, Journal of the National Cancer Institute.

Myelostimulatory activity of recombinant human interleukin-2 in mice.

D. Longo, J. Talmadge, F. Ruscetti, 1989, Blood.

Protective, restorative, and therapeutic properties of recombinant colony-stimulating factors.

J. Talmadge, M. Schneider, R. Pennington, 1989, Blood.

Preclinical approaches to the treatment of metastatic disease: therapeutic properties of rH TNF, rM IFN-gamma, and rH IL-2.

J. Talmadge, H. Phillips, M. Schneider, 1987, Drugs under experimental and clinical research.

Replication of Venezuelan equine encephalomyelitis virus in vitro. II. Viral growth response to selected nutritional additives in suspension cultures.

O. Bowersox, H. Tribble, H. J. Hearn, 1971, Applied microbiology.